Summary
Updated Aug 31, 2026
Nicole Murphy is Head of Pharm Ops and Tech of BIOGEN INC. (BIIB). 2 SEC Form 4 filings on record, most recently on 18 February 2026. Most recent open-market trade: bought $585 of BIIB on 18 February 2026. Lifetime open-market purchases: $585.
Recent Transactions
7Every recent SEC Form 4 transaction Nicole Murphy has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Nicole Murphy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Priya Singhal - $735K of BIIB open-market activity in the last 12 months
- Lloyd Minor - $240K of BIIB open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Nicole Murphy?
Nicole Murphy is a corporate insider, tracked as Head of Pharm Ops and Tech of BIOGEN INC. (BIIB). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Nicole Murphy last file a Form 4?
The most recent primary Form 4 on record is dated 18 February 2026, one of 2 filings going back to 2026.
Has Nicole Murphy been buying or selling stock?
Recorded transactions: 1 open-market purchase ($585) and 0 open-market sales across all tracked filings.
Where can I see all of Nicole Murphy's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Nicole Murphy and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
